Gene · 873
Papers2,488
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,488
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of three novel mutations in SLCO2A1 in Asian-Indians with Pachydermoperiostosis. | Indian J Med Res | 2023 | 37861627 | PubTator, text mining | PubMed |
| A review on the research progress of traditional Chinese medicine with anti-cancer effect targeting ferroptosis. | Chin Med | 2023 | 37833746 | PubTator, text mining | PubMed |
| Regeneration of neuromuscular synapses after acute and chronic denervation by inhibiting the gerozyme 15-prostaglandin dehydrogenase. | Sci Transl Med | 2023 | 37820010 | PubTator, text mining | PubMed |
| Fibrosis and bone marrow: understanding causation and pathobiology. | J Transl Med | 2023 | 37814319 | PubTator, text mining | PubMed |
| Pachydermoperiostosis: a case report of initial improvement with etoricoxib. | Ann Med Surg (Lond) | 2023 | 37811011 | PubTator, text mining | PubMed |
| Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma. | BMC Med | 2023 | 37775746 | PubTator, text mining | PubMed |
| Advances of autoimmune rheumatic diseases related to malignant tumors. | Inflamm Res | 2023 | 37768354 | PubTator, text mining | PubMed |
| Fast CU Partition Algorithm for Intra Frame Coding Based on Joint Texture Classification and CNN. | Sensors (Basel) | 2023 | 37765979 | PubTator, text mining | PubMed |
| Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach. | Cancers (Basel) | 2023 | 37760635 | PubTator, text mining | PubMed |
| Arachidonic acid metabolism in health and disease. | MedComm (2020) | 2023 | 37746665 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated activation of NR5A1 steers female human embryonic stem cell-derived bipotential gonadal-like cells towards a steroidogenic cell fate. | J Ovarian Res | 2023 | 37726790 | PubTator, text mining | PubMed |
| Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine. | Drug Metab Dispos | 2023 | 37722844 | PubTator, text mining | PubMed |
| Primary hypertrophic osteoarthropathy: genetics, clinical features and management. | Front Endocrinol (Lausanne) | 2023 | 37705574 | PubTator, text mining | PubMed |
| Microsomal glutathione transferase 1 in cancer and the regulation of ferroptosis. | Adv Cancer Res | 2023 | 37704286 | PubTator, text mining | PubMed |
| Towards the Identification of Biomarkers for Muscle Function Improvement in Myotonic Dystrophy Type 1. | J Neuromuscul Dis | 2023 | 37694373 | PubTator, text mining | PubMed |
| Dynamical modeling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity. | J Immunother Cancer | 2023 | 37678920 | PubTator, text mining | PubMed |
| Pachydermoperiostosis with bilateral ptosis and its associated systemic comorbidities: a rare case report. | Pan Afr Med J | 2023 | 37663630 | PubTator, text mining | PubMed |
Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | 37651309 | PubTator, text mining | PubMed |
| Nutritional Support for Liver Diseases. | Nutrients | 2023 | 37630830 | PubTator, text mining | PubMed |
| Expression of Prostaglandin Genes and β-Catenin in Whole Blood as Potential Markers of Muscle Degeneration. | Int J Mol Sci | 2023 | 37629065 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/873/papers?page=8